Skip to content

Sanara MedTech Inc. SMTI Cash & Equivalents

Cash & Equivalents at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.02B+49.0%
Stryker logo
StrykerSYK
$2.88B+24.1%
IAR
Integra LifeSciencesIART
$236.81M-1.0%
Solventum logo
SolventumSOLV
$561M+5.1%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$120.28M+108%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$36.52M+195%

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s cash & equivalents?
Sanara MedTech Inc. (SMTI) reported cash & equivalents of $13.59M in Q1 2026.
How has Sanara MedTech Inc.'s cash & equivalents changed year-over-year?
Sanara MedTech Inc.'s cash & equivalents decreased by 34.3% year-over-year, from $20.69M to $13.59M.
What is the long-term trend for Sanara MedTech Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s cash & equivalents has grown at a 105.2% compound annual growth rate (CAGR), from $455.37K to $16.58M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.